Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 3.64 USD 3.41% Market Closed
Market Cap: 358.1m USD

Intrinsic Value

The intrinsic value of one TOI stock under the Base Case scenario is 2.49 USD. Compared to the current market price of 3.64 USD, Oncology Institute Inc is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TOI Intrinsic Value
2.49 USD
Overvaluation 32%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Oncology Institute Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TOI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TOI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Oncology Institute Inc.

Explain Valuation
Compare TOI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TOI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncology Institute Inc

Current Assets 110.1m
Cash & Short-Term Investments 27.7m
Receivables 60m
Other Current Assets 22.5m
Non-Current Assets 53.5m
PP&E 34m
Intangibles 19m
Other Non-Current Assets 586k
Current Liabilities 65.6m
Accounts Payable 35.6m
Accrued Liabilities 20.3m
Other Current Liabilities 9.6m
Non-Current Liabilities 110.3m
Long-Term Debt 76.2m
Other Non-Current Liabilities 34.1m
Efficiency

Free Cash Flow Analysis
Oncology Institute Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oncology Institute Inc

Revenue
461m USD
Cost of Revenue
-392.7m USD
Gross Profit
68.3m USD
Operating Expenses
-109.4m USD
Operating Income
-41.1m USD
Other Expenses
-13.6m USD
Net Income
-54.7m USD
Fundamental Scores

TOI Profitability Score
Profitability Due Diligence

Oncology Institute Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Operating Margin is Increasing
Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Declining Gross Margin
17/100
Profitability
Score

Oncology Institute Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

TOI Solvency Score
Solvency Due Diligence

Oncology Institute Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
39/100
Solvency
Score

Oncology Institute Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TOI Price Targets Summary
Oncology Institute Inc

Wall Street analysts forecast TOI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TOI is 6.63 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.05 USD
39% Upside
Average
Price Target
6.63 USD
82% Upside
Highest
Price Target
8.4 USD
131% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Oncology Institute Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TOI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TOI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TOI stock?

The intrinsic value of one TOI stock under the Base Case scenario is 2.49 USD.

Is TOI stock undervalued or overvalued?

Compared to the current market price of 3.64 USD, Oncology Institute Inc is Overvalued by 32%.

Back to Top